For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety and efficacy profile of nipocalimab for generalized myasthenia gravis (gMG).
New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...
Guillain-Barre Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the ...
Abby Smith, 40, a NHS manager from Reading, has the rare autoimmune disease myasthenia gravis, which means she needs her ...
The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...
GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...
UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...
The symptoms: For two years, the office worker had found it harder to walk and developed an abnormal gait and hip pain.The bones in his hands also became enlarged, and he experienced reduced ...
Hospitals decide how much to bill Medicare for your care based on your diagnostic-related group (DRG). They then charge Medicare based on your DRG tier instead of separately for each of your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback